These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31381847)

  • 41. Treatment outcomes in REM sleep behavior disorder.
    McCarter SJ; Boswell CL; St Louis EK; Dueffert LG; Slocumb N; Boeve BF; Silber MH; Olson EJ; Tippmann-Peikert M
    Sleep Med; 2013 Mar; 14(3):237-42. PubMed ID: 23352028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia.
    van Geijlswijk IM; Mol RH; Egberts TC; Smits MG
    Psychopharmacology (Berl); 2011 Jul; 216(1):111-20. PubMed ID: 21340475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
    Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L
    Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems.
    Priano L; Esposti D; Esposti R; Castagna G; De Medici C; Fraschini F; Gasco MR; Mauro A
    J Nanosci Nanotechnol; 2007 Oct; 7(10):3596-601. PubMed ID: 18330178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
    Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
    Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the single-dose pharmacokinetics of once-daily cyclobenzaprine extended-release 30 mg and cyclobenzaprine immediate-release 10 mg three times daily in the elderly: a randomized, open-label, crossover study.
    Darwish M; Xie F
    Drugs Aging; 2009; 26(2):95-101. PubMed ID: 19220066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Melatonin to prevent migraine or tension-type headache in children.
    Miano S; Parisi P; Pelliccia A; Luchetti A; Paolino MC; Villa MP
    Neurol Sci; 2008 Sep; 29(4):285-7. PubMed ID: 18810607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteers.
    Yi S; Chung YJ; Kim TE; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Jun; 33(6):728-37. PubMed ID: 21704237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders.
    Carr R; Wasdell MB; Hamilton D; Weiss MD; Freeman RD; Tai J; Rietveld WJ; Jan JE
    J Pineal Res; 2007 Nov; 43(4):351-9. PubMed ID: 17910603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single- and Multiple-Dose Pharmacokinetics of Immediate-Release/Extended-Release Ibuprofen Tablets.
    Legg T; Paluch E; Jayawardena S
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):36-43. PubMed ID: 27364900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults.
    Reiz JL; Donnelly GA; Michalko K
    Clin Ther; 2008 Jan; 30(1):59-69. PubMed ID: 18343243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel sustained-release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers.
    Berends CL; Pagan L; van Esdonk MJ; Klarenbeek NB; Bergmann KR; Moerland M; van der Wel V; de Visser SJ; Büller H; de Loos F; de Vries WS; Waals H; de Leede LGJ; Burggraaf J; Kamerling IMC
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00739. PubMed ID: 33764642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The single-dose pharmacokinetics of NWP06, a novel extended-release methylphenidate oral suspension.
    Childress AC; Berry SA
    Postgrad Med; 2010 Sep; 122(5):35-41. PubMed ID: 20861586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
    Sikes C; Stark JG; McMahen R; Engelking D
    Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steady-state pharmacokinetics of a novel extended-release metformin formulation.
    Timmins P; Donahue S; Meeker J; Marathe P
    Clin Pharmacokinet; 2005; 44(7):721-9. PubMed ID: 15966755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder.
    Lalanne S; Fougerou-Leurent C; Anderson GM; Schroder CM; Nir T; Chokron S; Delorme R; Claustrat B; Bellissant E; Kermarrec S; Franco P; Denis L; Tordjman S
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: A randomized trial.
    Ahn JH; Kim M; Park S; Jang W; Park J; Oh E; Cho JW; Kim JS; Youn J
    Parkinsonism Relat Disord; 2020 Jun; 75():50-54. PubMed ID: 32480307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prophylactic Role of Oral Melatonin Administration on Neurogenesis in Adult Balb/C Mice during REM Sleep Deprivation.
    López-Armas G; Flores-Soto ME; Chaparro-Huerta V; Jave-Suarez LF; Soto-Rodríguez S; Rusanova I; Acuña-Castroviejo D; González-Perez O; González-Castañeda RE
    Oxid Med Cell Longev; 2016; 2016():2136902. PubMed ID: 27579149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.